China Pharma Holdings Inc. (AMEX:CPHI) traded with a subtraction of -$0.03 to $0.22 on Thursday, a downside of -8.61 percent. An average of 5,377,303 shares of common stock have been traded in the last five days. There was a gain of $0.0060 in the past week, and it reached a new high 3 times over the past 12 months. The last 20 days have seen an average of 1,605,161 shares traded, while the 50-day average volume stands at 737,826.
CPHI stock has decreased by -31.97% in the last month. The company shares reached their 1-month lowest point of $0.2102 on 08/17/23. With the stock rallying to its 52-week high on 01/12/23, shares of the company touched a low of $0.21 and a high of $2.46 in 52 weeks. It has reached a new high 4 times so far this year and lost -76.65% or -$0.7370 in price. In spite of this, the price is down -90.89% from the 52-week high.
Valuation Metrics
China Pharma Holdings Inc. (CPHIstock’s beta is 0.51. Other valuation ratios to consider include the trailing price-to-sales (P/S) ratio at 0.30, the price-to-book (PB) ratio at 0.51.
Financial Health
The quick ratio of China Pharma Holdings Inc. for the three months ended September 30 was 0.20, and the current ratio was 0.50, indicating that the company is not able to meet its debt obligations. Further, the company has a long term debt to equity ratio of 0.00 and a total debt to equity ratio of 1.18 for the quarter ending September 30. China Pharma Holdings Inc.’s EBITDA margin for the year ending September 30 is -10.47%. Its gross profit as reported stood at -$0.49 million compared to revenue of $8.1 million.
Earnings Surprise
In the quarter under review, the net income was down than the previous quarter. The company posted a net income of -$0.59 million in the quarter, while revenues were shrunk -50.85%. The analyst consensus anticipated China Pharma Holdings Inc.’s latest quarter earnings to come in at $1.2 per share, but it turned out to be $0.8, a -33.30% surprise. For the quarter, EBITDA amounted to $0.24 million. Shareholders own equity worth $11.43 million.
Technical Picture
From a technical analysis perspective, let’s take a brief look at China Pharma Holdings Inc. (CPHI) price momentum. RSI 9-day as of the close on 23 August was 37.51%, suggesting the stock is Neutral, with historical volatility in this time frame at 176.51%.
As of today, CPHI’s price is $0.2518 +2.78% or $0.0060 from its 5-day moving average. CPHI is currently trading -31.88% lower than its 20-day SMA and -43.08% lower than its 100-day SMA. However, the stock’s current price level is -43.08% below the SMA50 and -81.31% below the SMA200.
The stochastic %K and %D were 30.41% and 37.43%, respectively, and the average true range (ATR) was 0.0519. With the 14-day stochastic at 8.21% and the average true range at 0.0457, the RSI (14) stands at 37.42%. The stock has reached 0.0127 on the 9-day MACD Oscillator while the 14-day reading was at 0.0065.
Analyst Ratings
Rodman & Renshaw launched coverage on China Pharma Holdings Inc. (AMEX: CPHI) in its analyst report released on January 08, 2010. The firm assigned the stock a Mkt outperform rating. The consensus rating for China Pharma Holdings Inc. (CPHI) among analysts is Buy. According to current brokerage recommendations, 0 brokerage firms advise that investors sell CPHI, while 0 suggest investors hold. There are 0 analysts who rate the stock as underweight. The stock is rated overweight by 0 analysts, while 1 others rate it as a “buy”.
What is CPHI’s price target for the next 12 months?
Analysts predict a range of price targets between $45.00 and $45.00, with a median target of $45.00. Taking a look at these predictions, the average price target given by analysts for China Pharma Holdings Inc. (CPHI) stock is $45.00.
